Hypercoagulability in patients with stable COPD assessed by coagulation factor levels Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020
The importance of high plasma levels of factor VIIIc in the severity of pulmonary thromboembolism Source: Eur Respir J 2001; 18: Suppl. 33, 252s Year: 2001
Serum levels of proangiogenic factors before and after the correction of severe hypoxemia in COPD patients Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008
Serum levels of vascular endothelial growth factor (VEGF) are elevated in patients with acute exacerbated COPD Source: Eur Respir J 2005; 26: Suppl. 49, 350s Year: 2005
Elevated factor FVIII:C levels in patients with pulmonary hypertension: a marked of endothelial dysfunction? Source: Eur Respir J 2003; 22: Suppl. 45, 584s Year: 2003
Plasma high fibrinogen and low plasminogen levels predict poor prognosis in patients with inoperable chronic thromboembolic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012
Prothrombotic alterations to blood coagulation and fibrinolysis in clinically stable asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016
C-reactive protein levels and clinically important predictive outcomes in stable COPD patients Source: Eur Respir J 2006; 27: 902-907 Year: 2006
Relationship between circulating thrombomodulin levels and latent progression of atherosclerosis in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008
Effect of acute exacerbations on circulating thrombotic and fibrinolytic markers in COPD patients Source: Annual Congress 2011 - COPD exacerbation Year: 2011
Vascular endothelial growth factor (VEGF) levels in induced sputum and plasma in asymptomatic and COPD smokers. Correlation with airway and systemic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 652s Year: 2006
Thromboprophylaxis and the relationship between C-reactive protein and plasma fibrinogen in patients with acute exacerbations of COPD Source: Eur Respir J 2007; 30: Suppl. 51, 555s Year: 2007
Serum leptin and tumor necrosis factor – alpha levels and maximal exercise performance in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Respiratory muscles in disease Year: 2008
Elevated Von Willebrand Factor expression in the activated pulmonary endothelium of chronic thromboembolic pulmonary hypertension patients enhances platelet adhesion. Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020
Factors influencing induced sputum cytokines and VEGF in a population of stable COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 550s Year: 2006
Circulating vascular endothelial growth factor and osteoporosis in patients with COPD Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010
Elevated serum inflammatory markers in patients with stable COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009
Factors affecting C-reactive protein levels in patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007
Inflammatory mediators CRP, fibrinogen and leukocyte in stable COPD patients Source: Annual Congress 2007 - Airway regulation, provocation and monitoring I Year: 2007
VEGF serum levels in COPD patients without pulmonary hypertension – a case control study Source: International Congress 2018 – Biomarkers of COPD Year: 2018